/
/
/

Natco Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)794.90
Volume (₹)3.21 L
High (₹)794.90
Upper Circuit942.90
Low (₹)779.20
Lower Circuit628.60
Prev Close785.75
52W High (₹)1,216.81
Price781.60
52W Low (₹)773.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)15419.80 Cr
Div. Yield (%)0.63
PE Ratio13.48
Debt to Equity0.08
Price to Book1.89
Book Value510.98
EPS (TTM)58.33
Face Value2.00
ROE (%)16.30

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
NATCOPHARMNSE
LTP
1W Low
1W High
Market cap (₹)
1769.9-7.8 (-0.44%)
1722
1855
4,24,202Cr
10064+284 (2.90%)
9621.50
10064
2,64,141Cr
4650+36.6 (0.79%)
4532
4675
1,74,402Cr
2323-82.5 (-3.43%)
2206.10
2441.90
1,26,811Cr
1240.6-4.9 (-0.39%)
1182
1254.20
1,23,685Cr
1368.3+16.3 (1.21%)
1336.70
1368.30
1,11,868Cr
1396.9+18 (1.31%)
1357
1396.90
1,11,650Cr
2475-17.8 (-0.71%)
2457.90
2528
1,02,196Cr
1694.5+13.1 (0.78%)
1647.20
1697.40
96,951Cr
2015.9+4.9 (0.24%)
1974
2033.80
91,301Cr
781.6-0.8 (-0.10%)
779.20
800.90
15,420Cr

Key Highlights of Natco Pharma Ltd Balance Sheet

Natco Pharma Ltd balance sheet discloses shareholders' funds of ₹35.8Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹35.8Cr, and the reserves and surplus of the company is ₹7298.1Cr.

The company has its non-current liabilities with total liabilities of ₹8228.9Cr as of 2025-03-31.

The current liabilities are ₹864.6Cr as of 2025-03-31. At the same time, current assets are ₹4688Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹565.1Cr and tangible assets of ₹2516.8Cr, provided in the Natco Pharma Ltd financial statements.